Delivery Order SPE2DB20D3101-SPE2DB23FRRF4

Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,568,533,609 units of ACYCLOVIR 200 MG/5 ML SUSP 473ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order has a ceiling value of $1,938.57 and a completion date of June 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This delivery order is part of a larger $999,999,999.00...
This federal contract award is for the delivery of Acyclovir 1,000 mg/20 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $3,569.81 and is a delivery order contract with a firm fixed price. The award was made on May 17, 2023, with a completion date of May 18, 2023. The contract is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,037.41 delivery order is for the supply of 4,557,986,323 units of Acyclovir 1,000 mg/20 ml vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of ACYCLOVIR 200 MG/5 ML SUSP 473ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,579.31 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set aside and is awarded under a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 mg/20 ml acyclovir vials. The contract has a firm fixed price and has a total ceiling value of $1,934.24. The contract is not set-aside and is designated as an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a $1,787.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664392 - Acyclovir 200 mg/5 ml suspension in 473 ml bottles. The contract has a completion date of September 4, 2024 and was awarded on September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of Acyclovir 5% cream, a pharmaceutical product used to treat viral skin infections. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of Valacyclovir HCL 1 gram tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,189.34, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
This federal contract award is for the delivery of VALACYCLOVIR HYDROCHL, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,171.87 and a period of performance through May 2, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on February 21, 2024 and is not...
This federal contract award, valued at $1,698.37, was issued by the Defense agency Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Valacyclovir Hydrochloride, with a performance period ending on July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRRF4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp provides for the delivery of Acyclovir 200 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order is valued at $3,098.92 and has a period of performance through July 10, 2023.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:18 AM